{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:11:17Z","timestamp":1787595077162,"version":"build-2736575974"},"reference-count":90,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.cpcardiol.2021.100909","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T23:29:49Z","timestamp":1622244589000},"page":"100909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Anthracycline Associated Disturbances of Cardiovascular Homeostasis"],"prefix":"10.1016","volume":"47","author":[{"given":"Ashot","family":"Avagimyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lev","family":"Kakturskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyan","family":"Heshmat-Ghahdarijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Pogosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizal","family":"Sarrafzadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cpcardiol.2021.100909_bib0001","first-page":"2","article-title":"A virtual-hybrid approach to launching a cardio-oncology clinic during a pandemic","volume":"7","author":"Brown","year":"2021","journal-title":"Cardiooncology"},{"issue":"28","key":"10.1016\/j.cpcardiol.2021.100909_bib0002","doi-asserted-by":"crossref","first-page":"56","DOI":"10.25040\/lkv2019.04.051","article-title":"Cardiotoxicity of chemotherapeutic drugs (literature review and clinical case description)","volume":"4","author":"Avagimyan","year":"2019","journal-title":"Lviv Clin Bull"},{"issue":"8","key":"10.1016\/j.cpcardiol.2021.100909_bib0003","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2021.100909_bib0004","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbrc.2019.12.027","article-title":"Dexrazoxane ameliorates DOX-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes","volume":"523","author":"Yu","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"10.1016\/j.cpcardiol.2021.100909_bib0005","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1200\/JCO.2005.05.827","article-title":"Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity","volume":"23","author":"Ewer","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2021.100909_bib0006","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/mmr.2020.11752","article-title":"The mRNA expression of Il6 and Pdcd1 are predictive and protective factors for doxorubicin\u2011induced cardiotoxicity","volume":"23","author":"Kanno","year":"2021","journal-title":"Mol Med Rep"},{"issue":"8","key":"10.1016\/j.cpcardiol.2021.100909_bib0007","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12032-016-0801-5","article-title":"Cancer treatment-related cardiac toxicity: prevention, assessment and management","volume":"33","author":"Fanous","year":"2016","journal-title":"Med Oncol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2021.100909_bib0008","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline chemotherapy and cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0009","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fcvm.2020.00035","article-title":"Mechanisms of anthracycline-induced cardiotoxicity: is mitochondrial dysfunction the answer?","volume":"7","author":"Murabito","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"10.1016\/j.cpcardiol.2021.100909_bib0010","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.amjcard.2020.01.029","article-title":"Trastuzumab-related cardiotoxicity and cardiac care in patients with HER2 positive metastatic breast cancer","volume":"125","author":"Calvillo-Arg\u00fcelles","year":"2020","journal-title":"Am J Cardiol"},{"issue":"Sup. 7","key":"10.1016\/j.cpcardiol.2021.100909_bib0011","first-page":"55","article-title":"Cardiovascular toxicity induced by chemotherapy, targeted agents, and radiotherapy: ESMO Clinical Practice Guidelines \u0421linical practice guidelines","volume":"23","author":"Curigliano","year":"2012","journal-title":"Annals of Oncology"},{"issue":"36","key":"10.1016\/j.cpcardiol.2021.100909_bib0012","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0013","article-title":"Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment","author":"Saleh","year":"2020","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10.1016\/j.cpcardiol.2021.100909_bib0014","first-page":"15","article-title":"Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: preventive strategies and treatment","volume":"11","author":"Cai","year":"2019","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0015","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with DOX: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.cpcardiol.2021.100909_bib0016","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehaa006","article-title":"on behalf of the CARDIOTOX Registry Investigators. Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry","volume":"41","author":"L\u00f3pez-Send\u00f3n","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.cpcardiol.2021.100909_bib0017","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K","article-title":"Daunomycin an antitumor antibiotic, in the treatment of neoplastic disease Clinical evaluation with special reference to childhood leukemia","volume":"20","author":"Tan","year":"1967","journal-title":"Cancer"},{"issue":"65","key":"10.1016\/j.cpcardiol.2021.100909_bib0018","first-page":"3","article-title":"The discovery of daunorubicin","volume":"4","author":"Di Marco","year":"1981","journal-title":"Cancer. Treat Rep."},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0019","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcvm.2020.00026","article-title":"Cardiotoxicity of anthracyclines","volume":"7","author":"Cardinale","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-030-43032-0_15","article-title":"Anthracycline-induced cardiotoxicity: causes, mechanisms, and prevention","volume":"1257","author":"Bhagat","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2021.100909_bib0021","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2217\/pgs.14.179","article-title":"Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphoma","volume":"16","author":"Reichwagen","year":"2015","journal-title":"Pharmacogenomics"},{"issue":"5","key":"10.1016\/j.cpcardiol.2021.100909_bib0022","doi-asserted-by":"crossref","first-page":"e96055","DOI":"10.1371\/journal.pone.0096055","article-title":"Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up","volume":"9","author":"Len\u010dov\u00e1-Popelov\u00e1","year":"2014","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.cpcardiol.2021.100909_bib0023","doi-asserted-by":"crossref","first-page":"12995","DOI":"10.18632\/oncotarget.24457","article-title":"Disruption of ROCK1 gene restores autophagic flux and mitigates DOX-induced cardiotoxicity","volume":"9","author":"Shi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0024","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.2147\/DDDT.S251144","article-title":"Analysis of the DOX and DOXol in the plasma of breast cancer patients for monitoring the toxicity of DOX","volume":"14","author":"Harahap","year":"2020","journal-title":"Drug Des Devel Ther."},{"issue":"1","key":"10.1016\/j.cpcardiol.2021.100909_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10837450.2020.1832116","article-title":"Mitochondrial targeted DOX derivatives delivered by ROS-responsive nanocarriers to breast tumor for overcoming of multidrug resistance","volume":"26","author":"Zhong","year":"2021","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2021.100909_bib0026","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/toxsci\/kfy284","article-title":"DOX induces ER calcium release via SRC in rat ovarian follicles","volume":"168","author":"Aziz","year":"2019","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0027","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fcell.2020.00434","article-title":"Molecular mechanisms of cardiomyocyte death in drug-induced cardiotoxicity","volume":"8","author":"Ma","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2021.100909_bib0028","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline chemotherapy and cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"10.1016\/j.cpcardiol.2021.100909_bib0029","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/mol.119.115725","article-title":"Insights into DOX-induced cardiotoxicity: molecular mechanisms, preventive strategies, and early monitoring","volume":"96","author":"Wenningmann","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cbi.2019.01.032","article-title":"Oxidized phospholipids in DOX-induced cardiotoxicity","volume":"303","author":"Koleini","year":"2019","journal-title":"Chem Biol Interact"},{"issue":"3","key":"10.1016\/j.cpcardiol.2021.100909_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.06.007","article-title":"Autophagy and cancer therapy cardiotoxicity: from molecular mechanisms to therapeutic opportunities","volume":"1867","author":"Li","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1521020","article-title":"Oxidative stress and cellular response to DOX: a common factor in the complex milieu of anthracycline cardiotoxicity","volume":"2017","author":"Cappetta","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0033","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxlet.2019.02.013","article-title":"Oxidative stress injury in DOX-induced cardiotoxicity","volume":"307","author":"Songbo","year":"2019","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0034","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mito.2016.07.005","article-title":"Cardiac cytochrome c and cardiolipin depletion during anthracycline-induced chronic depression of mitochondrial function","volume":"30","author":"Pereira","year":"2016","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.cpcardiol.2021.100909_bib0035","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3904\/kjim.2016.017","article-title":"Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity","volume":"31","author":"Chung","year":"2016","journal-title":"Korean J Intern Med"},{"issue":"4","key":"10.1016\/j.cpcardiol.2021.100909_bib0036","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.stemcr.2016.08.009","article-title":"iPSC-MSCs with high intrinsic MIRO1 and sensitivity to TNF-\u03b1 yield efficacious mitochondrial transfer to rescue anthracycline-induced cardiomyopathy","volume":"7","author":"Zhang","year":"2016","journal-title":"Stem Cell Rep"},{"issue":"7","key":"10.1016\/j.cpcardiol.2021.100909_bib0037","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1021\/bc800117r","article-title":"In vitro and in vivo evaluation of DOX conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin alphavbeta3","volume":"19","author":"Ryppa","year":"2008","journal-title":"Bioconjug Chem"},{"issue":"7 Pt B","key":"10.1016\/j.cpcardiol.2021.100909_bib0038","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.bbamcr.2016.01.021","article-title":"New signal transduction paradigms in anthracycline-induced cardiotoxicity","volume":"1863","author":"Ghigo","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.cpcardiol.2021.100909_bib0039","doi-asserted-by":"crossref","first-page":"308","DOI":"10.31768\/2312-8852.2017.39(4):308-311","article-title":"L-arginine is an effective medication for prevention of endothelial dysfunction, a predictor of anthracycline cardiotoxicity in patients with acute leukemia","volume":"39","author":"Lymanets","year":"2017","journal-title":"Exp Oncol"},{"issue":"12","key":"10.1016\/j.cpcardiol.2021.100909_bib0040","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1111\/jcmm.13231","article-title":"Folic acid reduces DOX-induced cardiomyopathy by modulating endothelial nitric oxide synthase","volume":"21","author":"Octavia","year":"2017","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0041","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1152\/ajpheart.00795.2008","article-title":"Role of superoxide, nitric oxide, and peroxynitrite in DOX-induced cell death in vivo and in vitro","volume":"296","author":"Mukhopadhyay","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2021.100909_bib0042","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1152\/ajpcell.00356.2016","article-title":"DOX-induced nitrosamine stress is mitigated by vitamin C via the modulation of nitric oxide synthases","volume":"312","author":"Akolkar","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"10.1016\/j.cpcardiol.2021.100909_bib0043","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2021.100909_bib0044","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12192-015-0655-3","article-title":"HSP25 down-regulation enhanced p53 acetylation by dissociation of SIRT1 from p53 in DOX-induced H9c2 cell apoptosis","volume":"21","author":"Zhang","year":"2016","journal-title":"Cell Stress Chaperones"},{"issue":"1","key":"10.1016\/j.cpcardiol.2021.100909_bib0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/cvr\/cvs309","article-title":"Rac1 signalling mediates DOX-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways","volume":"97","author":"Ma","year":"2013","journal-title":"Cardiovasc Res"},{"issue":"15","key":"10.1016\/j.cpcardiol.2021.100909_bib0046","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1089\/ars.2020.8019","article-title":"Signaling pathways underlying anthracycline cardiotoxicity","volume":"32","author":"Sala","year":"2020","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"10.1016\/j.cpcardiol.2021.100909_bib0047","doi-asserted-by":"crossref","first-page":"65","DOI":"10.15407\/fz62.06.065","article-title":"DOX-indused disturbances of cardiomyocyte contractile activity","volume":"62","author":"Linnik","year":"2016","journal-title":"Fiziologichnyi Zhurnal"},{"issue":"11","key":"10.1016\/j.cpcardiol.2021.100909_bib0048","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.3390\/ijms19113480","article-title":"Anthracyclines as topoisomerase II poisons: from early studies to new perspectives","volume":"19","author":"Marinello","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.cpcardiol.2021.100909_bib0049","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2174\/0929867323666161214120355","article-title":"Topoisomerases and anthracyclines: recent advances and perspectives in anticancer therapy and prevention of cardiotoxicity","volume":"24","author":"Mordente","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104551","article-title":"Topoisomerase inhibitors: pharmacology and emerging nanoscale delivery systems","volume":"151","author":"Dehshahri","year":"2020","journal-title":"Pharmacol Res"},{"issue":"11","key":"10.1016\/j.cpcardiol.2021.100909_bib0051","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of DOX-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.cpcardiol.2021.100909_bib0052","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1158\/1078-0432.CCR-14-0821","article-title":"Twisting and ironing: DOX cardiotoxicity by mitochondrial DNA damage","volume":"20","author":"Nitiss","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0053","first-page":"131","article-title":"Anticancer and cardio-protective effects of liposomal DOX in the treatment of breast cancer","volume":"10","author":"Franco","year":"2018","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"Supplement_2","key":"10.1016\/j.cpcardiol.2021.100909_bib0054","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/ehaa946.3293","article-title":"Mitochondrial dysfunction associated with AC mode of chemotherapy intake","volume":"41","author":"Avagimyan","year":"2020","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.cpcardiol.2021.100909_bib0055","first-page":"8422","article-title":"DOX irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy","volume":"61","author":"Minotti","year":"2001","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.cpcardiol.2021.100909_bib0056","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nchembio807","article-title":"The role of iron regulatory proteins in mammalian iron homeostasis and disease","volume":"2","author":"Rouault","year":"2006","journal-title":"Nat Chem Biol"},{"issue":"21","key":"10.1016\/j.cpcardiol.2021.100909_bib0057","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1093\/nar\/gkn774","article-title":"Interaction of anthracyclines with iron responsive element mRNAs","volume":"36","author":"Canzoneri","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"10.1016\/j.cpcardiol.2021.100909_bib0058","doi-asserted-by":"crossref","first-page":"17179","DOI":"10.1074\/jbc.M111604200","article-title":"Transferrin receptor-dependent iron uptake is responsible for DOX-mediated apoptosis in endothelial cells: role of oxidant-induced iron signaling in apoptosis","volume":"277","author":"Kotamraju","year":"2002","journal-title":"J Biol Chem"},{"issue":"25","key":"10.1016\/j.cpcardiol.2021.100909_bib0059","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.2217\/fon-2018-0210","article-title":"Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling","volume":"14","author":"Reichardt","year":"2018","journal-title":"Future Oncol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2021.100909_bib0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cardfail.2012.11.006","article-title":"Circulating neuregulin during the transition from stage A to stage B\/C heart failure in a breast cancer cohort","volume":"19","author":"Geisberg","year":"2013","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.cpcardiol.2021.100909_bib0061","first-page":"34","article-title":"Cardiotoxicity and methods of its diagnosis in hematology patients","volume":"39","author":"Kuzmina","year":"2019","journal-title":"Siberian Scient Med J"},{"issue":"2","key":"10.1016\/j.cpcardiol.2021.100909_bib0062","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/toxsci\/kfu150","article-title":"Examining the protective role of ErbB2 modulation in human-induced pluripotent stem cell-derived cardiomyocytes","volume":"141","author":"Eldridge","year":"2014","journal-title":"Toxicol Sci"},{"issue":"8","key":"10.1016\/j.cpcardiol.2021.100909_bib0063","doi-asserted-by":"crossref","first-page":"H1271","DOI":"10.1152\/ajpheart.00517.2014","article-title":"ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against DOX cardiotoxicity","volume":"309","author":"Belmonte","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2021.100909_bib0064","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/CIRCULATIONAHA.113.002203","article-title":"An engineered bivalent neuregulin protects against DOX-induced cardiotoxicity with reduced proneoplastic potential","volume":"128","author":"Jay","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12947-015-0011-x","article-title":"The role of renin angiotensin system antagonists in the prevention of DOX and trastuzumab induced cardiotoxicity","volume":"13","author":"Akolkar","year":"2015","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0066","doi-asserted-by":"crossref","first-page":"e48771","DOI":"10.1371\/journal.pone.0048771","article-title":"Inhibition of cyclooxygenase-2 reduces hypothalamic excitation in rats with adriamycin-induced heart failure","volume":"7","author":"Zheng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0067","article-title":"Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system-from molecular mechanisms to therapeutic applications","author":"Sobczuk","year":"2020","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0068","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3390\/cells8101224","article-title":"Exosome treatment enhances anti-inflammatory M2 macrophages and reduces inflammation-induced pyroptosis in DOX-induced cardiomyopathy","volume":"8","author":"Singla","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0069","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"hERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0070","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1152\/physrev.00036.2011","article-title":"hERG K(+) channels: structure, function, and clinical significance","volume":"92","author":"Vandenberg","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0071","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1113\/JP272864","article-title":"Potassium channels in the heart: structure, function and regulation","volume":"595","author":"Grandi","year":"2017","journal-title":"J Physiol"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0072","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.tips.2017.06.004","article-title":"Towards a structural view of drug binding to hERG K+ channels","volume":"38","author":"Vandenberg","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0073","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3389\/fphar.2019.01572","article-title":"an update on the structure of hERG","volume":"10","author":"Butler","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0074","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0075","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8547846","article-title":"Hypoxia-inducible factors as an alternative source of treatment strategy for cancer","author":"Akanji","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0076","first-page":"767","article-title":"Role of peroxisome proliferator-activated receptor-alpha in fasting-mediated oxidative stress. Free Radic","volume":"47","author":"Abdelmegeed","year":"2009","journal-title":"Biol Med"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0077","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pharmthera.2009.03.003","article-title":"Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease","volume":"122","author":"Robinson","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0078","article-title":"PPAR\u03b1 ameliorates DOX-induced cardiotoxicity by reducing mitochondria-dependent apoptosis via regulating MEOX1","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0079","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12012-015-9332-0","article-title":"Peroxisome proliferator-activated receptor-\u03b1 inhibition protects against DOX-induced cardiotoxicity in mice","volume":"16","author":"Rahmatollahi","year":"2016","journal-title":"Cardiovasc Toxicol"},{"issue":"1-2","key":"10.1016\/j.cpcardiol.2021.100909_bib0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-019-03656-y","article-title":"Role of oxidative stress-related biomarkers in heart failure: galectin 3, \u03b11-antitrypsin and LOX-1: new therapeutic perspective?","volume":"464","author":"Lubrano","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0081","first-page":"25","article-title":"Fisetin ameliorates atherosclerosis by regulating PCSK9 and LOX-1 in apoE-\/- mice","volume":"21","author":"Yan","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0082","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154994","article-title":"Deletion of LOX-1 protects against heart failure induced by DOX","volume":"11","author":"Yokoyama","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0083","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-020-03729-y","article-title":"Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways","author":"Wang","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0084","doi-asserted-by":"crossref","DOI":"10.1007\/s12012-020-09626-x","article-title":"Mitochondrial sirtuins and doxorubicin-induced cardiotoxicity","author":"He","year":"2021","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/jpi.12176","article-title":"Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin","volume":"57","author":"Govender","year":"2014","journal-title":"J Pineal Res"},{"issue":"7","key":"10.1016\/j.cpcardiol.2021.100909_bib0086","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/cells8070686","article-title":"Mitochondrial homeostasis and cellular senescence","volume":"8","author":"Vasileiou","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0087","unstructured":"Avagimyan A, Aznauryan A, Aznauryan S. Morphological aspects of myocardial alteration during doxorubicin intake. Morphology St. Petersburg (Publication of International Association of Morphologists). 2020;2-3:8. ISSN 1026-3543."},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0088","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"issue":"suppl. 1","key":"10.1016\/j.cpcardiol.2021.100909_bib0089","first-page":"3","article-title":"Pathophysiology of anthracycline cardiotoxicity","volume":"17","author":"Donato","year":"2016","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2021.100909_bib0090","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3390\/cells8101224","article-title":"Exosome treatment enhances anti-inflammatory M2 macrophages and reduces inflammation-induced pyroptosis in doxorubicin-induced cardiomyopathy","volume":"8","author":"Singla","year":"2019","journal-title":"Cells"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:57:47Z","timestamp":1758938267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280621001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":90,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0146280621001249"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100909","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anthracycline Associated Disturbances of Cardiovascular Homeostasis","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100909"}}